CTKB financials
Cytek Biosciences (CTKB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CTKB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $201.49M | $104.46M | -$40.38M | -$66.54M | – |
| 2024 | $200.45M | $111.11M | -$20.52M | -$6.02M | – |
| 2023 | $193.01M | $109.43M | -$27.84M | -$12.15M | -0.09 |
| 2022 | $164.04M | $100.97M | -$1.80M | $2.58M | 0.02 |
| 2021 | $127.95M | $79.14M | $9.16M | $0.00 | 0.00 |
| 2020 | $92.84M | $51.71M | $13.66M | $3.22M | 0.10 |
- CTKB revenue was $201.49M in fiscal 2025, net income -$66.54M.
Updated 2026-11-11 00:46 UTC